Skip to content

Doxylamine

Published: July 26, 2026Updated: August 25, 2026

Doxylamine is a first-generation antihistamine used to treat allergic conditions such as hay fever, allergic rhinitis, and mild skin reactions. It is also commonly used as a short-term sleep aid due to its sedating properties. The medication works by blocking histamine H1 receptors, reducing allergic symptoms like sneezing, itching, and runny nose.

Quick summary

Doxylamine is an antihistamine used for allergies and as a sleep aid, working by blocking histamine receptors.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ATC
R06AA09
RxNorm
3498
Generic
Doxylamine
Class
atc-r06
Brands
Diclegis, Wal-Som (doxylamine), Bonjesta, Unisom, Nocto, Zzzquil Ultra, Aldex AN
Availability
otc
Pregnancy
A
Lactation
caution
Half-life (h)
10
Onset (min)
30
Duration (h)
8
Routes
oral
Forms
tablet, delayed-release tablet, capsule, oral solution, chewable tablet
Regions
United States, Canada, United Kingdom, Australia, European Union, New Zealand
Monitoring
sedation, anticholinergic effects, cognitive impairment in elderly

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
25mg once daily
Maximum
consult physician
Frequency
at bedtime
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
12.5mg once daily
Maximum
consult physician
Frequency
at bedtime
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
12.5mg once daily
Maximum
consult physician
Frequency
at bedtime
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Doses above 1000 mg may cause serious toxicity; fatalities have been reported at various dose levels
Chronic overdose: Prolonged use exceeding recommended doses may lead to cumulative anticholinergic toxicity
Immediate actions
Gastric decontamination with activated charcoal if within 1-2 hours of ingestion, supportive care, airway management, cardiac monitoring
Antidote
No specific antidote; N-acetylcysteine for acetaminophen co-ingestion (if present in combination product)(Supportive care is mainstay; N-acetylcysteine highly effective for acetaminophen toxicity if given within 8-24 hour window)
Poison Control: 1-800-222-1222

Special Populations

9 groups
⚠

pregnancy

first trimester
caution
FDA Category
A
Dose Adjustment

standard dose when used for nausea/vomiting of pregnancy

Key Recommendations

doxylamine/pyridoxine combination (Diclegis) is FDA-approved for nausea/vomiting in pregnancy; avoid using as sleep aid in first trimester unless specifically indicated

Monitor

standard prenatal care

Use with caution and monitor for adverse effects.

⚠

pregnancy

second third trimester
caution
FDA Category
A
Dose Adjustment

standard dose

Key Recommendations

continue use for nausea/vomiting of pregnancy as needed; avoid as sleep aid unless benefits clearly outweigh risks

Monitor

standard prenatal monitoring

Use with caution and monitor for adverse effects.

⚠

lactation

breastfeeding
caution
FDA Category
N
Dose Adjustment

no specific adjustment

Key Recommendations

small amounts excreted in breast milk; monitor infant for excessive drowsiness

Monitor

observe infant for sedation or irritability

Use with caution and monitor for adverse effects.

⚠

geriatric

elderly 65 years
caution
FDA Category
N
Dose Adjustment

start with lowest effective dose

Key Recommendations

use with caution due to anticholinergic effects; increased risk of falls, confusion, and cognitive impairment; consider alternative sleep aids

Monitor

monitor for sedation, dizziness, cognitive changes, and fall risk

Use with caution and monitor for adverse effects.

✗

pediatric_age

children under 12
contraindicated
FDA Category
N
Dose Adjustment

not recommended

Key Recommendations

do not use for pediatric insomnia; contraindicated in children with asthma, narrow-angle glaucoma, or urinary retention

Monitor

not applicable

Use of this medication in this population requires careful consideration of risks and benefits.

✓

renal_impairment

mild to moderate
safe
FDA Category
N
Dose Adjustment

no adjustment needed

Key Recommendations

no dose adjustment required for mild to moderate renal impairment

Monitor

standard monitoring

⚠

renal_impairment

severe
caution
FDA Category
N
Dose Adjustment

reduce dose or increase dosing interval

Key Recommendations

use with caution; consider dose reduction; monitor for extended sedation

Monitor

monitor for prolonged sedative effects

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

mild to moderate
caution
FDA Category
N
Dose Adjustment

consider reduced dose

Key Recommendations

metabolized by liver; use reduced initial dose and titrate carefully

Monitor

monitor for increased sedation

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

severe
caution
FDA Category
N
Dose Adjustment

significant dose reduction recommended

Key Recommendations

use with caution; significant dose reduction required; avoid prolonged use

Monitor

close monitoring for sedation and adverse effects

Use with caution and monitor for adverse effects.

Statistics and clinical data

drug_classWHO
2023

Drug class

Value:Antihistamine (Ethanolamine derivative)

First-generation H1 antihistamine agent

usageFDA
2023

Common uses

Value:Sleep aid, Insomnia, Nausea and vomiting in pregnancy

Therapeutic indications for doxylamine succinate

prescribingFDA
2023

FDA pregnancy category approval

Value:Approved for nausea and vomiting in pregnancy

Diclegis (doxylamine/pyridoxine) approved 2013

pharmacologyFDA
2023

Mechanism of action

Value:H1 receptor antagonist (inverse agonist)

Primary pharmacological mechanism

Treatment of seasonal and perennial allergic rhinitis, allergic conjunctivitis, urticaria (hives), and dermatographism. Also used as a sedative-hypnotic for short-term insomnia and occasionally for nausea and vomiting in early pregnancy.

Doxylamine is a competitive H1 receptor antagonist that blocks histamine from binding to its receptors, preventing allergic symptoms. As a first-generation antihistamine, it readily crosses the blood-brain barrier and has anticholinergic properties, contributing to its sedating effect.

May cause significant drowsiness and impaired coordination; avoid driving or operating machinery. Should not be combined with alcohol or other CNS depressants. Contraindicated in patients with narrow-angle glaucoma, urinary retention, or severe respiratory disease. Use with caution in elderly patients due to increased sensitivity to anticholinergic effects and fall risk.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy